October 24, 2020

Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

In this episode, we are joined by Internal Medicine PGY-3s and soon-to-be fellows Dr. Carrie Mahurin and Dr. Jen Bergeron. Together, they review the evidence for or against a broadened therapeutic role of SGLT2 Inhibitors beyond diabetes treatment, in light of new trials suggesting efficacy in heart failure and chronic kidney disease management.


Guests: Dr. Carrie Mahurin, MD, PGY3 at UVMMC, and Dr. Jen Bergeron, MD, PGY3 at UVMMC


Thumbnail by Kate Hliznitsova on Unsplash

More episodes

Load more

Podbean App

Play this podcast on Podbean App